Your browser doesn't support javascript.
loading
Complete response of penile mycosis fungoides with systemic brentuximab therapy.
Schaufler, Christian; Ferenczi, Katalin; Hegde, Upendra; Ristau, Benjamin T.
Afiliação
  • Schaufler C; University of Connecticut Health Center, Division of Urology, 263 Farmington Avenue, Farmington, CT, 06030, United States.
  • Ferenczi K; University of Connecticut Health Center, Division of Dermatology, 263 Farmington Avenue, Farmington, CT, 06030, United States.
  • Hegde U; University of Connecticut Health Center, Division of Medicine, 263 Farmington Avenue, Farmington, CT, 06030, United States.
  • Ristau BT; University of Connecticut Health Center, Division of Urology, 263 Farmington Avenue, Farmington, CT, 06030, United States.
Urol Case Rep ; 34: 101460, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33194554
Mycosis fungoides with penile involvement is extremely rare. Previous reports have shown successful treatment with imiquimod or a combination of beam radiation and chemotherapy. We present a patient with mycosis fungoides and penile involvement. The penile lesions were initially treated with topical imiquimod; however, he developed worsening glandular lesions and discharge. Therefore the treatment was discontinued. Subsequent treatment with brentuximab (anti-CD30) targeted therapy resulted in complete resolution of the penile lesions. To our knowledge, this represents the first case of a complete penile mycosis fungoides response to brentuximab therapy. Brentuximab may be considered for refractory penile mycoses fungoides.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Urol Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Urol Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos